- Technology and Data
- Front End Sales and Marketing
- Allergy
- HIV
- Women's Health
- Migraine
- Compounding
- Continuous Glucose Monitoring
- Mental Health Awareness
- Veterinary Pharmacy
- CBD
- Infectious Disease
- Eye Health
- Digestive Health
- Biosimilars
- Influenza
- Shingles
- COPD Management
- Pediatrics
- Generics
- Pain Management
- COVID-19
- Immunization
- Oncology
- Anticoagulants
- Autoimmune Diseases
- Dermatology
- Diabetes
- Respiratory
- Heart Health
- Cardiovascular Clinical Consult
FDA wants your views on electronic drug labeling
Would you like to receive updated drug labeling information electronically, rather than in paper insert form? The FDA is planning a hearing to explore this issue.
Would you like to receive updated drug labeling information electronically, rather than in paper insert form? The FDA is planning a hearing to explore this issue. The hearing will be held on April 27 at FDA headquarters at 5600 Fishers Lane, third floor, conference rooms D and E, Rockville, Md. The agency said it would like to hear from manufacturers, pharmacists, wholesalers, consumers, and others on the subject. For more information, go to http://a257.g.akamaitech.net/7/257/2422/01jan20071800/edocket.access.gpo.gov/2007/07-1604.htm.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
